We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.37B
AUM Growth
+$60.5M
(+4.6%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
1.72%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
266
New
15
Increased
109
Reduced
90
Closed
11
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$15.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$13.8M |
| 3 |
Palo Alto Networks
PANW
|
+$12.4M |
| 4 |
Honeywell
HON
|
+$10.3M |
| 5 |
Moody's
MCO
|
+$6.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$18.2M |
| 2 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$12M |
| 3 |
Check Point Software Technologies
CHKP
|
+$10.5M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$10.1M |
| 5 |
CVS Health
CVS
|
+$6.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.2% |
| 2 | Financials | 15.18% |
| 3 | Technology | 14.24% |
| 4 | Industrials | 10.89% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Idexx Laboratories
IDXX
$41.7B
| $985K | 0.07% |
8,736
| – | – |
2016 Q2
1 quarter
|
|
127
Boeing
BA
$146B
| $983K | 0.07% |
7,460
-463
| -6% | -$61K |
2013 Q2
13 quarters
|
|
128
Public Storage
PSA
$54B
| $960K | 0.07% |
4,300
| – | – |
2016 Q2
1 quarter
|
|
|
CCMP
129
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $959K | 0.07% |
18,124
| – | – |
2013 Q2
13 quarters
|
|
130
Chubb
CB
$135B
| $925K | 0.07% |
7,361
-177
| -2% | -$22.5K |
2016 Q1
2 quarters
|
|
131
DuPont de Nemours
DD
$17.4B
| $924K | 0.07% |
7,040
+2,370
| +51% | +$316K |
2013 Q2
13 quarters
|
|
132
Oracle
ORCL
$396B
| $922K | 0.07% |
23,493
+2,494
| +12% | +$102K |
2013 Q2
13 quarters
|
|
133
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $908K | 0.07% |
18,176
| – | – |
2013 Q2
13 quarters
|
|
|
IMPV
134
DELISTED
Imperva, Inc.
IMPV
| $889K | 0.07% |
16,544
+1,370
| +9% | +$63.6K |
2016 Q2
1 quarter
|
|
135
Walmart Inc
WMT
$922B
| $882K | 0.06% |
36,681
-135
| -0.4% | -$3.27K |
2013 Q2
13 quarters
|
|
136
ConocoPhillips
COP
$171B
| $879K | 0.06% |
20,226
-456
| -2% | -$18.9K |
2013 Q2
13 quarters
|
|
137
American Electric Power
AEP
$68.7B
| $864K | 0.06% |
13,455
-754
| -5% | -$50.7K |
2014 Q4
7 quarters
|
|
138
Yum! Brands
YUM
$40B
| $838K | 0.06% |
12,831
+152
| +1% | +$9.7K |
2013 Q2
13 quarters
|
|
|
RDS.A
139
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $807K | 0.06% |
16,687
-629
| -4% | -$30.8K |
2013 Q2
13 quarters
|
|
140
Simon Property Group
SPG
$64.3B
| $778K | 0.06% |
3,760
| – | – |
2016 Q2
1 quarter
|
|
141
Integra LifeSciences
IART
$1.03B
| $749K | 0.05% |
18,144
+1,544
| +9% | +$64.7K |
2015 Q3
4 quarters
|
|
|
MMP
142
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $719K | 0.05% |
10,159
+215
| +2% | +$15.3K |
2013 Q2
13 quarters
|
|
143
DELISTED
Synchronoss Technologies
SNCR
| $718K | 0.05% |
1,938
+200
| +12% | +$70.7K |
2014 Q1
10 quarters
|
|
144
iShares Russell 1000 Growth ETF
IWF
$127B
| $716K | 0.05% |
27,500
-2,184
| -7% | -$56.8K |
2015 Q2
5 quarters
|
|
145
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $696K | 0.05% |
18,573
-2,888
| -13% | -$106K |
2013 Q2
13 quarters
|
|
146
SEI Investments
SEIC
$12.6B
| $696K | 0.05% |
15,258
| – | – |
2016 Q1
2 quarters
|
|
147
Diageo
DEO
$51.2B
| $685K | 0.05% |
5,905
+475
| +9% | +$54.3K |
2016 Q2
1 quarter
|
|
148
iShares Russell 1000 Value ETF
IWD
$83.1B
| $667K | 0.05% |
6,312
-147
| -2% | -$15.5K |
2015 Q2
5 quarters
|
|
149
Truist Financial
TFC
$55.7B
| $667K | 0.05% |
17,702
+3,370
| +24% | +$126K |
2016 Q2
1 quarter
|
|
150
Amgen
AMGN
$230B
| $663K | 0.05% |
3,971
-555
| -12% | -$93.9K |
2013 Q3
12 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Cambridge Trust held 266 positions worth $1.37B, up 4.6% from $1.31B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cambridge Trust's Q3 2016 filing shows 15 new, 109 increased, 90 reduced and 11 closed positions. Its largest new stake was Meta Platforms (Facebook): 111,565 shares worth $14.3M. The largest sale was Wells Fargo, an estimated $18.2M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.
- Cambridge Trust's largest Q3 2016 buy was Meta Platforms (Facebook): 111,565 shares worth $14.3M.
- Cambridge Trust added most to UnitedHealth in Q3 2016, an estimated $15.8M increase.
- Cambridge Trust's biggest Q3 2016 reduction was Wells Fargo, cutting an estimated $18.2M.
- Cambridge Trust fully exited LinkedIn Corporation in Q3 2016, selling an estimated $1.25M.
- Cambridge Trust's ten largest holdings make up 25% of its $1.37B portfolio in Q3 2016.
- Cambridge Trust opened 15 new positions and closed 11 in Q3 2016.
- Cambridge Trust's portfolio value rose 4.6% quarter-over-quarter to $1.37B.
Based on Cambridge Trust's 13F filing for Q3 2016, filed 8 Nov 2016.